Pulmonary vein isolation for the treatment of drug-refractory atrial fibrillation in adults with congenital heart disease

Congenital Heart Disease

Volumn 7, Issue 4, 2012, Pages 392-399

  Philip, Femi ^a   Muhammad, Kamran I ^a   Agarwal, Shikar ^a   Natale, Andrea ^b   Krasuski, Richard A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TEXAS CARDIAC ARRHYTHMIA INSTITUTE   (United States)

Author keywords

Adult Congenital Heart Disease; Antiarrhythmic Therapy; Atrial Fibrillation; Pulmonary Vein Isolation; Structural Heart Disease

Indexed keywords

ANTIARRHYTHMIC AGENT;

ADULT; AORTA COARCTATION; ARTICLE; BLAND GARLAND WHITE SYDROME; CARDIOMYOPATHY; COHORT ANALYSIS; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; EBSTEIN ANOMALY; EMBOLISM; FALLOT TETRALOGY; FEMALE; FOLLOW UP; GREAT VESSELS TRANSPOSITION; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM DEFECT; HEART EJECTION FRACTION; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART SINGLE VENTRICLE; HEART VENTRICLE SEPTUM DEFECT; HEMATOMA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY VEIN ISOLATION; PULMONARY VEIN OBSTRUCTION; STROKE;

ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PULMONARY VEINS; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 84864291035     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2012.00649.x     Document Type: Article

References (22)

1. Warnes CA, Williams RG, Bashore TM. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52:e1-121.
2. Go AS, Hylek EM, Phillips KA. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-2375.
3. Wyse DG, Waldo AL, DiMarco JP. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825-1833.
4. Hagens VE, Ranchor AV, Van Sonderen E. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol. 2004;43:241-247.
5. Carlsson J, Miketic S, Windeler J. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol. 2003;41:1690-1696.
6. Pedersen OD, Brendorp B, Elming H. Does conversion and prevention of atrial fibrillation enhance survival in patients with left ventricular dysfunction? Evidence from the Danish Investigations of Arrhythmia and Mortality ON Dofetilide/(DIAMOND) study. Card Electrophysiol Rev. 2003;7:220-224.
7. Deedwania PC, Singh BN, Ellenbogen K. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators. Circulation. 1998;98:2574-2579.
8. Corley SD, Epstein AE, DiMarco JP. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation. 2004;109:1509-1513.
9. Verma A, Natale A. Should atrial fibrillation ablation be considered first-line therapy for some patients? Why atrial fibrillation ablation should be considered first-line therapy for some patients. Circulation. 2005;112:1214-1222; discussion 1231.
10. Khan MN, Jais P, Cummings J. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med. 2008;359:1778-1785.
11. Blackstone EH. Comparing apples and oranges. J Thorac Cardiovasc Surg. 2002;123:8-15.
12. Berruezo A, Tamborero D, Mont L. Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. Eur Heart J. 2007;28:836-841.
13. Pappone C, Santinelli V, Manguso F. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation. 2004;109:327-334.
14. Tsai CF, Tai CT, Hsieh MH. Initiation of atrial fibrillation by ectopic beats originating from the superior vena cava: electrophysiological characteristics and results of radiofrequency ablation. Circulation. 2000;102:67-74.
15. Pappone C, Oreto G, Rosanio S. Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation. 2001;104:2539-2544.
16. Stabile G, Bertaglia E, Senatore G. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur Heart J. 2006;27:216-221.
17. Oral H, Scharf C, Chugh A. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation. 2003;108:2355-2360.
18. Pappone C, Rosanio S. Evolution of non-pharmacological curative therapy for atrial fibrillation. Where do we stand today? Int J Cardiol. 2003;88:135-142.
19. Pappone C, Rosanio S, Augello G. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized longterm study. J Am Coll Cardiol. 2003;42:185-197.
20. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res. 2002;54:230-246.
21. Pratola C, Baldo E, Notarstefano P. Radiofrequency ablation of atrial fibrillation: is the persistence of all intraprocedural targets necessary for long-term maintenance of sinus rhythm? Circulation. 2008;117:136-143.
22. Cappato R, Calkins H, Chen SA. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 2005;111:1100-1105.